# LA Improves the Prognosis of Patients With ICVD

> **NCT05845983** · NA · NOT_YET_RECRUITING · sponsor: **Huaqiu Zhang** · enrollment: 236 (estimated)

## Conditions studied

- Ischemia
- Cerebrovascular Ischemia
- Cognitive Impairment

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus acidophilus
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT05845983
- **Lead sponsor:** Huaqiu Zhang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-05-04
- **Primary completion:** 2026-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05845983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05845983, "LA Improves the Prognosis of Patients With ICVD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05845983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*